The clinical management of bacterial infections has become a growing global public health
challenge. Such therapy is presently limited to antibiotics, but the misuse of antibiotics has …

With the prevalence of antibiotic-resistant bacteria, novel antibacterial strategies are urgently
needed. In recent years, several antibiotics-independent physical approaches have …

Gold and silver nanoparticles (NPs) are widely used in the biomedical research both in the
therapeutic and the sensing/diagnostics fronts. Both metals share some common optical …

Bacterial infection continues to be one of the biggest threats to human health. The
therapeutic effect is significantly reduced as a result of the development of super-bacteria …

The spread of antibiotic resistance and increasing prevalence of biofilm-associated
infections is driving demand for new means to treat bacterial infection. Nanotechnology …

Infectious diseases caused by pathogenic bacteria, especially multidrug‐resistant bacteria,
and their global spreading have become serious public health concerns. Early diagnosis …

Bacteria can infect the human body and cause disease, which endangers public safety. The
emergence of multidrug-resistant bacteria poses a great challenge on the treatment of …

Injudicious use of antibiotics has been the main driver of severe bacterial non-susceptibility
to commonly available antibiotics (known as drug resistance or antimicrobial resistance), a …

With the wide utilization of antibiotics, antibiotic‐resistant bacteria have been often
developed more frequently to cause potential global catastrophic consequences. Emerging …

Heterometallic nanomaterials (HMNMs) display superior physicochemical properties and
stability to monometallic counterparts, accompanied by wider applications in the fields of …